Disposable Infusion Extension Lines Are Suitable For Administering Contrast Medium/Fluids during Imaging Procedures
Disposable
infusion extension lines are made of medical grade polycarbonate and PU (or
PVC). These lines are used in continuous infusion and IV sampling studies in
large and small animals. Infusion extension lines are used to extend infusion
lines and offer a greater radius of motion for more mobility when administering
infusion therapies. Introduced in the early 1990s, extension sets, are used to
overcome workplace needlestick injuries and leaky ports.
Disposable
infusion extension lines include, primary IV tubing that is used to infuse
continuous or intermittent fluids or medication. Secondary IV tubing is shorter
in length than primary tubing, with no access ports or backcheck valve. It is used
to infuse intermittent medications or fluids when connected to a primary line
via an access port.
Some
of the benefits of disposable
infusion extension lines include, high patient comfort, high quality
kink-resistant tubing with smooth inner surfaces for laminar and non –
turbulent flow, suitable for administering contrast medium/fluids during
imaging procedures, and availability of various tube lengths based on customer
requirements. These infusion extension lines also offer separation of
administration and insertion sites, low mechanical irritation of blood vessel,
and decrease in risk of thrombotic events such as thrombophlebitis. They also
increase safety for hospital staff and patients as they help reduce needlestick
injuries and leaky ports.
Increase
in commercialization of intravenous infusion is expected to boost demand for disposable
infusion extension lines. In October 2020, Knight Therapeutics Inc., a Canada-based
public specialty pharmaceutical company, signed a new exclusive distribution
agreement with Gilead Sciences, Inc., a U.S.-based biopharmaceutical company, for
the commercialization of AmBisome (liposomal amphotericin B), a non-pyrogenic
lyophilized sterile intravenous infusion of liposomal amphotericin B. It is
indicated for the treatment of severe deep mycotic infections and/or endemic
and opportunistic systemic mycosis, in Brazil.
Comments
Post a Comment